Kenshiro Takemoto
Hiroshima University(JP)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Renal cell carcinoma treatment, Urinary and Genital Oncology Studies, Prostate Cancer Diagnosis and Treatment, Urinary Bladder and Prostate Research
Most-Cited Works
- → Clinicopathological significance of the overexpression of MUC1 in upper tract urothelial carcinoma and possible application as a diagnostic marker(2022)17 cited
- → The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy(2020)17 cited
- → BACH1 promotes clear cell renal cell carcinoma progression by upregulating oxidative stress‐related tumorigenicity(2022)16 cited
- → CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma(2021)13 cited
- → Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomy(2022)11 cited
- → P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma(2021)10 cited
- → Tumor heterogeneity evaluated by computed tomography detects muscle-invasive upper tract urothelial carcinoma that is associated with inflammatory tumor microenvironment(2021)10 cited
- → DDX41 expression is associated with tumor necrosis in clear cell renal cell carcinoma and in cooperation with VHL loss leads to worse prognosis(2022)8 cited
- → Retrospective evaluation of the improvement in the urinary status‐related quality of life after robot‐assisted radical prostatectomy(2023)7 cited
- → Influence of best objective response to first‐line treatment on survival outcomes in advanced urothelial carcinoma in the era of sequential therapy with enfortumab vedotin(2025)7 cited